Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Volume: 18

Issue: 4

Year of Publication: 2022

Affiliated Institutions:  Department of Neurology and Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA. Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Sanders-Brown Center on Aging and Alzheimer's Disease Center, University of Kentucky, Lexington, Kentucky, USA. Department of Psychology and Latin American Latino Studies Institute, Fordham University, New York, New York, USA. Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. Alzheimer's Center, Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.

Abstract summary 

Authors & Co-authors:  Babulal Ganesh M GM Franzen Sanne S Abner Erin L EL Smith Jade Emily JE van den Berg Esther E Mindt Monica Rivera MR van Bruchem-Visser Rozermarijn Lidewij RL Schneider Lon S LS Prins Niels D ND Papma Janne M JM

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Hood CM, Gennuso KP, Swain GR, Catlin BB. County health rankings: Relationships between determinant factors and health outcomes. Am J Prev Med. 2016;50(2):129–135
Authors :  10
Identifiers
Doi : 10.1002/alz.12611
SSN : 1552-5279
Study Population
Male,Female
Mesh Terms
Alzheimer Disease
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
United States